Callum Arthurs

Callum Arthurs

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XDXinyi Du-Harpur
Xinyi Du-Harpur
CACallum Arthurs
Callum Arthurs
CGClarisse Ganier
Clarisse Ganier
RWRick Woolf
Rick Woolf
ZLZainab Laftah
Zainab Laftah
MLMagnus D. Lynch
Magnus D. Lynch

12 May 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CACallum Arthurs
Callum Arthurs
Alejandro Suárez-BonnetAlejandro Suárez-Bonnet
Alejandro Suárez-Bonnet
CWClaire Willis
Claire Willis
BXBoyu Xie
Boyu Xie
NMNatalie Machulla
Natalie Machulla
AAAamir Ahmed
Aamir Ahmed
Equine penile squamous cell carcinoma (EpSCC) is a relatively common cutaneous neoplasm with a poor prognosis. In this study, we aimed to determine the protein expression and colocalisation of FRA1, c-Myc, Cyclin D1, and MMP7 in normal (NT), tumour (T), hyperplastic epidermis and/or squamous papilloma (Hyp/Pap), poorly-differentiated (PDSCC), or well-differentiated (WDSCC) EpSCC using a tissue array approach. Further objectives were to correlate protein expression to (i) levels of inflammation, using a convolutional neural network (ii) equine papillomavirus 2 (EcPV2) infection, detected using PCR amplification. We found an increase in expression of FRA1 in EpSCC compared to NT samples. c-Myc expression was higher in Hyp/Pap and WDSCC but not PDSCC whereas MMP7 was reduced in WDSCC compared with NT. There was a significant increase in the global intersection coefficient (GIC) of FRA1 with MMP7, c-Myc, and Cyclin D1 in EpSCC. Conversely, GIC for MMP7 with c-Myc was reduced in EpSCC tissue. Inflammation was positively associated with EcPV2 infection in both NT and EpSCC but not Hyp/Pap. Changes in protein expression could be correlated with EcPV2 for Cyclin D1 and c-Myc. Our results evaluate novel biomarkers of EpSCC and a putative correlation between the expression of biomarkers, EcPV2 infection and inflammation.

29 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CGClarisse Ganier
Clarisse Ganier
XDXinyi Du-Harpur
Xinyi Du-Harpur
NHNasrat Harun
Nasrat Harun
BWBo Wan
Bo Wan
CACallum Arthurs
Callum Arthurs
MLMagnus D. Lynch
Magnus D. Lynch
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is associated with a wide range of systemic manifestations. Several observations support a role for vascular endothelial dysfunction in the pathogenesis including an increased incidence of thrombotic events and coagulopathy and the presence of vascular risk factors as an independent predictor of poor prognosis. It has recently been reported that endothelitis is associated with viral inclusion bodies suggesting a direct role for SARS-CoV-2 in the pathogenesis. The ACE2 receptor has been shown to mediate SARS-CoV-2 uptake and it has been proposed that CD147 (BSG) can function as an alternative cell surface receptor. To define the endothelial cell populations that are susceptible to infection with SARS-CoV-2, we investigated the expression of ACE2 as well as other genes implicated in the cellular entry of SARS-Cov-2 in the vascular endothelium through the analysis of single cell sequencing data derived from multiple human tissues (skin, liver, kidney, lung and intestine). We found that CD147 ( BSG ) but not ACE2 is detectable in vascular endothelial cells within single cell sequencing datasets derived from multiple tissues in healthy individuals. This implies that either ACE2 is not expressed in healthy tissue but is instead induced in response to SARS-Cov2 or that SARS-Cov2 enters endothelial cells via an alternative receptor such as CD147.

4 November 2020 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
NJNavroop Johal
Navroop Johal
KCKevin Cao
Kevin Cao
CACallum Arthurs
Callum Arthurs
MMMichael Millar
Michael Millar
CTChristopher Thrasivoulou
Christopher Thrasivoulou
CFChristopher Fry
Christopher Fry

27 July 2018 in Diagnostics
Verified
Journal Article
Open access
PDF file
KCKevin Cao
Kevin Cao
CACallum Arthurs
Callum Arthurs
AAAli Atta-Ul
Ali Atta-Ul
MMMichael Millar
Michael Millar
MBMariana Beltran
Mariana Beltran
CTChristopher Thrasivoulou
Christopher Thrasivoulou
Prostate cancer is the third highest cause of male mortality in the developed world, with the burden of the disease increasing dramatically with demographic change. There are significant limitations to the current diagnostic regimens and no established effective screening modality. To this end, research has discovered hundreds of potential ‘biomarkers’ that may one day be of use in screening, diagnosis or prognostication. However, the barriers to bringing biomarkers to clinical evaluation and eventually into clinical usage have yet to be realised. This is an operational challenge that requires some new thinking and development of paradigms to increase the efficiency of the laboratory process and add ‘value’ to the clinician. Value comes in various forms, whether it be a process that is seamlessly integrated into the hospital laboratory environment or one that can provide additional ‘information’ for the clinical pathologist in terms of risk profiling. We describe, herein, an efficient and tissue-conserving pipeline that uses Tissue Microarrays in a semi-automated process that could, one day, be integrated into the hospital laboratory domain, using seven putative prostate cancer biomarkers for illustration.

4 March 2021 in Bioinformatics
Verified
Journal Article
Open access
PDF file
CACallum Arthurs
Callum Arthurs
AAAamir Ahmed
Aamir Ahmed
Tissue array (TA) staining, combined with whole slide imaging (WSI) methods facilitate discovery of biomarkers for diagnosis, prognostication and disease stratification. A key impediment in TA WSI analysis is handling missing tissue and artefacts when identifying tissue cores before quantitative, standardized downstream analysis. There is a need for an open access, user friendly, integrated analysis of the WSI generated using TAs in clinical and scientific research laboratories. We have developed QuArray (Quantitative Array Application) for image export and signal analysis of TAs using WSI. The application input is a WSI and a corresponding TA configuration file. QuArray identifies and exports core images and analyses chromogen staining in a simple graphical user interface. Output data is saved to file for further analysis including indexed data. Available for download from https://github.com/c-arthurs/QuArray under an MIT licence. Supplementary data are available at Bioinformatics online.